BURU Q3 2023 Earnings Significant Loss Per Share Amid PreRevenue Stage CBAN Q1 2026 Earnings Earnings Fall Short of Estimates as EPS Misses by 1777 AMT Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction Fulcrum Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Analyst Expectations QVCGA Q3 2025 Earnings Deep Loss Reported Amidst No Revenue Disclosure GWAV Q3 2023 Earnings Significant EPS Loss Amidst Operational Challenges